ADM Addiction Treatment Modalities & Therapeutic Approaches 3

Question 1

Extended-release naltrexone (Vivitrol) for opioid use disorder offers which key clinical advantage over daily oral naltrexone?

Accepted Answer

Improved adherence due to monthly injection eliminating daily pill burden

Answer

Monthly injectable naltrexone removes the need for daily adherence decisions, substantially improving treatment compliance compared to oral formulations.

Question 2

The Community Reinforcement Approach (CRA) for addiction treatment is primarily based on which theoretical framework?

Accepted Answer

Operant behavioral principles that identify and restructure environmental contingencies

Answer

CRA uses operant conditioning principles to rearrange social and environmental reinforcers so that a sober lifestyle becomes more rewarding than substance use.

Question 3

A patient with severe alcohol use disorder presents during medically supervised withdrawal. Which benzodiazepine property is most important when selecting an agent for withdrawal management in a patient with advanced liver disease?

Accepted Answer

Minimal hepatic metabolism (e.g., oxazepam, lorazepam)

Answer

Oxazepam and lorazepam undergo direct glucuronidation rather than extensive hepatic oxidative metabolism, making them safer in patients with severe liver disease.

Question 4

Which statement best describes the role of Twelve-Step Facilitation (TSF) therapy in addiction treatment?

Accepted Answer

It is a structured clinical intervention designed to promote engagement with AA/NA and acceptance of addiction

Answer

TSF is a manualized clinical approach that encourages patients to accept their addiction, engage in step work, and actively participate in 12-step mutual-help programs.

Question 5

For a patient with co-occurring opioid use disorder and chronic pain, which treatment strategy is generally recommended?

Accepted Answer

Treat both conditions simultaneously, often with buprenorphine which provides analgesia while treating OUD

Answer

Buprenorphine is an ideal option for co-occurring OUD and chronic pain because it provides analgesia while simultaneously treating addiction, supporting integrated care.

(ADM) Board Certified Addiction Medicine Specialist Practice Test

(ADM) Board Certified Addiction Medicine Specialist Practice Test

ADM Addiction Treatment Modalities & Therapeutic Approaches 3